News Image

Esperion Reports First Quarter 2025 Financial Results

Provided By GlobeNewswire

Last update: May 6, 2025

– Q1 2025 Total Revenue of $65.0 Million, a Decrease of 53% Y/Y; Adjusting for One Time Milestone Received in Q1 2024, Total Revenue Grew 63% Y/Y –

– Q1 2025 U.S. Net Product Revenue Grew 41% Y/Y to $34.9 Million –

Read more at globenewswire.com

ESPERION THERAPEUTICS INC

NASDAQ:ESPR (7/11/2025, 8:08:01 PM)

After market: 1.19 0 (0%)

1.19

-0.05 (-4.03%)



Find more stocks in the Stock Screener

Follow ChartMill for more